ALPS Medical Breakthroughs ETF Rating $27.04 -1.48 (-5.17%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock ALPS Medical Breakthroughs ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SBIO Aggregate RatingModerate Buy 2.89Holdings in SBIO have an aggregate rating of Moderate Buy based on 783 analyst ratings issued in the past year covering 98 companies (99.7% of the portfolio).SBIO Aggregate Price Target$27.02High Prediction$27.02Average Prediction$27.02Low Prediction$27.02Holdings in SBIO have an aggregate price target of $27.02 and a range of $27.02 to $27.02 covering 98 companies (99.7% of the portfolio).SBIO Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy56 Buy rating(s)Moderate Buy29 Moderate Buy rating(s)Hold11 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ALPS Medical Breakthroughs ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 98 SBIO Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.58%AXSMAxsome Therapeutics$111.47-4.4%4.7495 of 5 stars3.00$167.64 50.4%15Analyst ForecastShort Interest ↓News CoverageGap Down4.51%VRNAVerona Pharma$58.56-7.8%2.3466 of 5 stars3.14$69.14 18.1%7Positive News4.51%ALKSAlkermes$32.52-1.5%4.6077 of 5 stars2.69$39.38 21.1%13Positive News3.67%PTCTPTC Therapeutics$46.62-8.5%3.8712 of 5 stars2.53$63.77 36.8%15Analyst ForecastHigh Trading Volume3.31%RNAAvidity Biosciences$26.73-9.5%2.5437 of 5 stars3.00$66.69 149.6%13Positive News3.21%ZLABZai Lab$37.33+3.3%2.1671 of 5 stars2.75$47.37 26.9%4Gap UpHigh Trading Volume2.95%AKROAkero Therapeutics$38.59-4.7%4.3272 of 5 stars3.00$76.29 97.7%92.87%RYTMRhythm Pharmaceuticals$50.11-5.4%4.4167 of 5 stars2.92$69.46 38.6%132.73%CRNXCrinetics Pharmaceuticals$30.61-8.7%4.3727 of 5 stars2.92$73.00 138.5%132.66%MRUSMerus$39.46-6.3%2.3476 of 5 stars3.13$85.31 116.2%16News CoverageHigh Trading Volume2.65%PTGXProtagonist Therapeutics$46.86-3.1%3.603 of 5 stars3.00$62.56 33.5%9Positive News2.38%ACADACADIA Pharmaceuticals$16.31-1.8%4.1479 of 5 stars2.50$23.93 46.8%16Gap Up2.22%XENEXenon Pharmaceuticals$30.62-8.7%2.4083 of 5 stars3.00$57.38 87.4%9Analyst UpgradeNews CoveragePositive NewsHigh Trading Volume2.22%FOLDAmicus Therapeutics$7.96-2.5%4.0425 of 5 stars2.78$16.75 110.6%92.18%MLTXMoonLake Immunotherapeutics$36.35-7.0%2.1447 of 5 stars3.00$80.50 121.5%82.03%NAMSNewAmsterdam Pharma$18.27-10.8%2.6065 of 5 stars3.00$43.33 137.2%6Short Interest ↑News CoveragePositive NewsHigh Trading Volume1.93%VCELVericel$43.09-3.4%3.173 of 5 stars3.00$62.29 44.6%7Positive News1.90%MIRMMirum Pharmaceuticals$43.92-2.5%4.3884 of 5 stars3.09$58.20 32.5%11Positive News1.85%EWTXEdgewise Therapeutics$20.04-8.9%1.9371 of 5 stars2.88$45.38 126.5%81.84%DNLIDenali Therapeutics$12.25-9.9%4.3815 of 5 stars2.94$37.20 203.6%18Positive News1.77%CGONCG Oncology$22.03-10.1%1.1495 of 5 stars3.10$63.88 190.0%10Earnings ReportAnalyst ForecastNews Coverage1.64%TARSTarsus Pharmaceuticals$49.06-4.5%2.7039 of 5 stars3.00$63.67 29.8%71.55%IRONDisc Medicine$47.20-4.9%3.134 of 5 stars3.09$93.80 98.7%11Positive News1.51%AGIOAgios Pharmaceuticals$27.38-6.5%4.3374 of 5 stars2.56$56.57 106.6%9Short Interest ↓Positive News1.51%APGEApogee Therapeutics$35.51-4.9%2.1932 of 5 stars3.00$92.17 159.5%6Positive News1.43%VERAVera Therapeutics$22.01-8.4%3.103 of 5 stars3.20$64.67 193.8%10News CoveragePositive News1.43%GLPGGalapagos$24.79-1.3%0.5248 of 5 stars1.50$25.33 2.2%81.39%BCRXBioCryst Pharmaceuticals$7.25-3.4%4.2916 of 5 stars2.86$15.57 114.9%7Short Interest ↑News CoveragePositive News1.30%MNKDMannKind$4.95-1.7%2.4958 of 5 stars3.13$9.21 86.3%8Positive News1.26%IMCRImmunocore$28.63-3.5%1.9154 of 5 stars2.54$65.64 129.3%13Positive NewsHigh Trading Volume1.25%IDYAIDEAYA Biosciences$14.74-10.0%3.3841 of 5 stars2.93$53.58 263.5%15News CoverageHigh Trading Volume1.16%CLDXCelldex Therapeutics$16.85-7.2%1.6255 of 5 stars2.89$54.33 222.5%91.11%LQDALiquidia$14.53-1.5%2.5628 of 5 stars3.11$26.63 83.3%91.05%VRDNViridian Therapeutics$12.59-6.6%1.2373 of 5 stars2.75$35.70 183.7%12Positive News1.00%GPCRStructure Therapeutics$15.81-8.7%2.0562 of 5 stars3.00$81.29 414.2%8News CoverageHigh Trading Volume0.97%AUPHAurinia Pharmaceuticals$8.05+0.1%2.9807 of 5 stars3.00$11.50 42.9%20.96%NVAXNovavax$6.02-6.2%3.6491 of 5 stars2.43$18.00 199.3%7News Coverage0.80%VIRVir Biotechnology$6.18-4.6%3.6611 of 5 stars2.83$35.67 476.9%6News CoveragePositive News0.76%RCUSArcus Biosciences$7.70-2.0%2.2115 of 5 stars3.00$30.25 293.1%100.75%NTLAIntellia Therapeutics$6.64-6.6%4.4457 of 5 stars2.63$37.56 465.3%190.70%DAWNDay One Biopharmaceuticals$7.61-4.1%2.9042 of 5 stars3.13$32.29 324.5%80.69%XNCRXencor$9.69-9.0%3.7072 of 5 stars3.13$34.38 254.9%80.68%REPLReplimune Group$8.38-14.1%3.6734 of 5 stars3.13$19.43 132.0%8Positive News0.67%AVXLAnavex Life Sciences$8.04-6.4%3.7937 of 5 stars3.33$44.00 447.6%3Analyst ForecastNews CoveragePositive NewsGap Down0.67%PRAXPraxis Precision Medicines$35.94-5.1%2.1317 of 5 stars2.78$123.33 243.2%90.66%PHVSPharvaris$15.01-4.4%1.5446 of 5 stars3.00$40.50 169.9%40.60%MLYSMineralys Therapeutics$13.85-12.8%3.07 of 5 stars3.00$27.00 95.0%3Gap UpHigh Trading Volume0.57%PRTAProthena$11.75-5.1%3.2799 of 5 stars2.75$55.00 368.3%8News CoveragePositive News0.55%DNTHDianthus Therapeutics$16.85-7.1%1.3498 of 5 stars3.22$54.33 222.5%90.54%AVBPArriVent BioPharma$18.01-2.6%1.4285 of 5 stars3.17$39.00 116.5%6Positive News0.53%NUVBNuvation Bio$1.76-0.3%1.9646 of 5 stars3.25$8.75 398.6%40.53%IMNMImmunome$6.25-7.2%2.1133 of 5 stars3.00$25.50 308.1%6Gap Up0.50%ANABAnaptysBio$18.43-0.9%2.9537 of 5 stars2.73$35.11 90.5%11Buyback Announcement0.46%CAPRCapricor Therapeutics$9.48-0.1%2.0426 of 5 stars3.00$34.50 263.8%6Positive News0.45%FLGTFulgent Genetics$17.29+2.3%2.8816 of 5 stars2.00$16.00 -7.4%1Short Interest ↑Positive News0.44%URGNUroGen Pharma$10.61-4.0%3.7899 of 5 stars3.17$38.20 259.9%6Positive News0.39%TBPHTheravance Biopharma$9.03+1.1%1.8003 of 5 stars2.40$13.75 52.4%50.38%KROSKeros Therapeutics$9.57-6.1%3.6445 of 5 stars2.57$42.33 342.6%14Analyst ForecastNews Coverage0.38%AUTLAutolus Therapeutics$1.41-9.4%3.032 of 5 stars3.00$9.32 563.3%6Analyst ForecastPositive News0.38%ERASErasca$1.21-12.0%3.7645 of 5 stars3.00$4.83 301.1%60.37%SVRASavara$2.87+3.4%1.5404 of 5 stars2.83$8.83 208.3%6Earnings ReportAnalyst RevisionGap Up0.35%CELCCelcuity$9.28-8.3%1.6098 of 5 stars3.14$30.17 225.2%7Earnings ReportAnalyst ForecastNews CoverageHigh Trading Volume0.35%STOKStoke Therapeutics$6.24-6.2%3.538 of 5 stars3.13$24.67 295.6%8Positive News0.34%TRMLTourmaline Bio$14.21-6.6%1.9499 of 5 stars3.00$45.20 218.1%6Positive News0.32%RNACCartesian Therapeutics$12.39-6.0%2.5074 of 5 stars2.80$42.14 240.3%10Gap Up0.32%ALDXAldeyra Therapeutics$5.48-4.8%2.0117 of 5 stars3.00$10.00 82.6%2News CoverageHigh Trading Volume0.31%UPBUpstream Bio$6.69+9.2%N/A3.00$56.50 745.2%4Positive NewsGap Up0.31%ATXSAstria Therapeutics$5.39+0.8%1.7156 of 5 stars3.29$26.60 394.0%70.30%AMLXAmylyx Pharmaceuticals$3.36-5.2%3.1589 of 5 stars2.71$7.33 118.6%70.29%RAPPRapport Therapeutics$9.58-4.5%1.7417 of 5 stars3.00$35.00 265.5%3Short Interest ↑0.28%RIGLRigel Pharmaceuticals$17.15-4.7%2.9394 of 5 stars2.40$36.80 114.6%5Positive News0.28%ARCTArcturus Therapeutics$9.43-11.0%3.3761 of 5 stars3.13$59.20 528.0%8Positive News0.26%ZBIOZenas Biopharma$7.56-4.3%N/A3.00$40.00 429.1%2News CoverageGap Up0.26%AURAAura Biosciences$5.67-3.3%2.2947 of 5 stars3.29$23.00 306.0%70.25%OLMAOlema Pharmaceuticals$3.30-12.3%2.6919 of 5 stars3.00$26.75 711.6%40.24%CMPSCOMPASS Pathways$2.80-2.3%3.3564 of 5 stars3.00$20.20 622.7%60.23%SLRNAcelyrin$2.53+2.2%3.1408 of 5 stars2.40$9.60 280.2%5Positive News0.22%VNDAVanda Pharmaceuticals$4.50-2.1%4.2734 of 5 stars3.00$16.50 267.1%2Analyst ForecastNews CoveragePositive News0.22%MBXMBX Biosciences$6.86-7.0%1.9389 of 5 stars3.00$37.25 442.7%40.22%ANNXAnnexon$1.82-6.0%2.2412 of 5 stars3.00$18.67 928.5%4Positive News0.22%ITOSiTeos Therapeutics$5.64-5.6%2.6711 of 5 stars3.00$25.75 357.0%40.20%IRWDIronwood Pharmaceuticals$1.42-3.7%3.8262 of 5 stars2.50$8.60 507.8%6Analyst UpgradeShort Interest ↑0.19%YMABY-mAbs Therapeutics$4.50+1.5%3.6798 of 5 stars2.91$18.30 307.1%110.18%ELDNEledon Pharmaceuticals$3.22-5.0%1.7554 of 5 stars3.00$12.50 288.2%20.16%CRGXCARGO Therapeutics$4.11+0.9%3.139 of 5 stars1.86$15.00 265.4%7Positive News0.15%RZLTRezolute$2.92+0.6%2.8096 of 5 stars3.13$24.38 735.9%8News CoveragePositive News0.15%NMRANeumora Therapeutics$0.91-8.8%3.1873 of 5 stars2.44$10.14 1,012.2%90.15%ACRSAclaris Therapeutics$1.50-2.3%2.4069 of 5 stars3.13$11.67 680.4%8Short Interest ↑0.14%FDMT4D Molecular Therapeutics$2.99-7.6%2.8514 of 5 stars2.56$26.71 795.0%90.13%LRMRLarimar Therapeutics$2.00-7.0%1.9292 of 5 stars3.08$20.22 911.1%120.12%ALECAlector$1.17-5.3%3.8063 of 5 stars2.14$3.50 200.4%7Gap Up0.11%ZNTLZentalis Pharmaceuticals$1.39-12.9%1.8903 of 5 stars2.44$8.24 495.3%9Earnings ReportAnalyst RevisionNews Coverage0.11%ENTAEnanta Pharmaceuticals$5.34-3.3%3.9585 of 5 stars2.80$17.25 223.0%50.10%PROKProKidney$0.83-4.8%2.0571 of 5 stars2.50$5.00 499.5%40.09%KYTXKyverna Therapeutics$1.98+2.8%1.5773 of 5 stars3.00$18.67 840.9%7Earnings ReportAnalyst ForecastNews Coverage0.08%PLRXPliant Therapeutics$1.39+3.2%4.2017 of 5 stars2.00$13.31 855.7%12Short Interest ↑Gap DownHigh Trading Volume0.08%MGNXMacroGenics$1.22-4.3%3.8915 of 5 stars2.36$7.38 507.0%110.05%STROSutro Biopharma$0.60-8.5%4.2704 of 5 stars2.22$6.63 1,013.4%9 This page (NYSEARCA:SBIO) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ALPS Medical Breakthroughs ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SBIO Stock Free SBIO Stock Alerts